Who owns VNDA?
Institutional ownership of Vanda Pharmaceuticals Inc. from Form 13F, Q2 2026
172 institutional managers reported holding Vanda Pharmaceuticals Inc. (VNDA) in Form 13F filings for Q2 2026, with 49,682,616 shares worth $304M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 3,145,940 shares (+6.8%). 28 opened new positions and 25 sold out.
- Funds holding
- 172
- Value held
- $304M
- New / sold out
- 28 / 25
- Net shares, same filers
- +6.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of VNDA
Share of 13F holdings is each fund's shares as a share of the 49,682,616 VNDA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- AQR Capital Management LLC Added+$11.6M
- Qube Research & Technologies Ltd New+$4.5M
- Marshall Wace, LLP Added+$3.9M
- State Street Corp Added+$3.1M
- BlackRock, Inc. Added+$2.3M
- Y-Intercept (Hong Kong) Ltd New+$1.8M
- Los Angeles Capital Management LLC Added+$1.7M
- Goldman Sachs Group Inc Added+$1.2M
- Point72 Asset Management, L.P. Added+$917K
- Northern Trust Corp Added+$916K
Biggest sellers in Q2 2026
- Empire Financial Management Company, LLC Sold out-$6.4M
- AIGH Capital Management LLC Trimmed-$4.3M
- Renaissance Technologies LLC Trimmed-$1.9M
- Millennium Management LLC Trimmed-$1.7M
- Jane Street Group, LLC Sold out-$1.5M
- Woodline Partners LP Sold out-$1.4M
- State of Wisconsin Investment Board Sold out-$1.4M
- Arrowstreet Capital, Limited Partnership Trimmed-$1.3M
- Connor, Clark & Lunn Investment Management Ltd. Trimmed-$989K
- Virtu Financial LLC Trimmed-$717K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $45.7M and sold $28.1M; 67 added and 54 trimmed.
Schedule 13D and 13G filings on VNDA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Vanda Pharmaceuticals Inc.Schedule 13G
- 2026-08-19MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Vanda Pharmaceuticals Inc.Schedule 13G
- 2026-08-13AQR CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Vanda Pharmaceuticals Inc.Schedule 13G
- 2026-05-12STATE STREET CORP SCHEDULE 13G filed by Vanda Pharmaceuticals Inc.Schedule 13G
- 2025-07-01MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Vanda Pharmaceuticals Inc.Schedule 13G
Questions about VNDA ownership
- Who owns VNDA stock?
- 172 institutional investment managers reported VNDA positions in their Form 13F filings for Q2 2026, holding 49,682,616 shares worth $304M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling VNDA?
- In Q2 2026, 28 managers opened new VNDA positions, 67 added, 54 trimmed and 25 sold out. Managers that filed in both quarters added a net 3,145,940 shares.
- How current is this VNDA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to VNDA by CUSIP. Options are left out. VNDA news and filings · VNDA insider trades · Top funds